ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Efficacy and Safety of Dapagliflozin by Baseline Glycemic Status: A Prespecified Analysis From the DAPA-CKD Trial

Persson, Frederik*; Rossing, Peter; Vart, Priya; Chertow, Glenn M.; Hou, Fan Fan; Jongs, Niels; McMurray, John J., V; Correa-Rotter, Ricardo; Bajaj, Harpreet S.; Stefansson, Bergur, V; Toto, Robert D.; Langkilde, Anna Maria; Wheeler, David C.; Heerspink, Hiddo J. L.南方医科大学
Diabetes Care2021-8DOI: 10.2337/dc21-0300
38被引9阅读
引用收藏
分享

摘要

OBJECTIVE The Dapagliflozin and Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) study demonstrated risk reduction for kidney and cardiovascular outcomes with dapagliflozin versus placebo in participants with chronic kidney disease (CKD) with and without diabetes. We compared outcomes according to baseline glycemic status. RESEARCH DESIGN AND METHODS We enrolled participants with CKD, estimated glomerular filtration rate (eGFR) 25-75 mL/min/1.73 m(2), and urinary albumin-to-creatinine ratio 200-5,000 mg/g. The primary composite end point was sustained eGFR decline >= 50%, end-stage kidney disease, or kidney or cardiovascular death. RESULTS Of 4,304 participants, 738 had normoglycemia, 660 had prediabetes, and 2,906 had type 2 diabetes. The effect of dapagliflozin on the primary outcome was consistent (P for interaction = 0.19) in normoglycemia (hazard ratio [HR] 0.62 [95% CI 0.39, 1.01]), prediabetes (HR 0.37 [0.21, 0.66]), and type 2 diabetes (HR 0.64 [0.52, 0.79]). We found no evidence for effect modification on any outcome. Adverse events were similar, with no major hypoglycemia or ketoacidosis in participants with normoglycemia or prediabetes. CONCLUSIONS Dapagliflozin safely reduced kidney and cardiovascular events independent of baseline glycemic status.

相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Diabetes Care
发表日期
2021-08
卷期
第 44 卷, 第 8 期
页码
1894-1897
DOI
10.2337/dc21-0300
语言
ENGLISH
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
National Institute of Diabetes and Digestive and Kidney Diseases

作者

  • P

    Persson, Frederik (通讯) (第一作者)

  • R

    Rossing, Peter

查看全部 14 位作者收起作者
  • V

    Vart, Priya

  • C

    Chertow, Glenn M.

  • H

    Hou, Fan Fan

    southern med univ

  • J

    Jongs, Niels

  • M

    McMurray, John J., V

  • C

    Correa-Rotter, Ricardo

  • B

    Bajaj, Harpreet S.

  • S

    Stefansson, Bergur, V

  • T

    Toto, Robert D.

  • L

    Langkilde, Anna Maria

  • W

    Wheeler, David C.

  • H

    Heerspink, Hiddo J. L.

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417